BR9606767A - Uso de compostos e processo para tratamento vasodilatador e profilaxia de por exemplo isquemia cerebral angina pectoris ou sindrome de raynaud - Google Patents

Uso de compostos e processo para tratamento vasodilatador e profilaxia de por exemplo isquemia cerebral angina pectoris ou sindrome de raynaud

Info

Publication number
BR9606767A
BR9606767A BR9606767A BR9606767A BR9606767A BR 9606767 A BR9606767 A BR 9606767A BR 9606767 A BR9606767 A BR 9606767A BR 9606767 A BR9606767 A BR 9606767A BR 9606767 A BR9606767 A BR 9606767A
Authority
BR
Brazil
Prior art keywords
raynaud
prophylaxis
syndrome
compounds
angina pectoris
Prior art date
Application number
BR9606767A
Other languages
English (en)
Inventor
Michael Shalmi
Jan Ulrik Weis
Niels Korsgaard
Birgitte Hjort Guldhammer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9606767A publication Critical patent/BR9606767A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9606767A 1995-01-20 1996-01-10 Uso de compostos e processo para tratamento vasodilatador e profilaxia de por exemplo isquemia cerebral angina pectoris ou sindrome de raynaud BR9606767A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK6795 1995-01-20
DK77595 1995-06-30
PCT/DK1996/000013 WO1996022093A1 (en) 1995-01-20 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis

Publications (1)

Publication Number Publication Date
BR9606767A true BR9606767A (pt) 1997-12-30

Family

ID=26063230

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606767A BR9606767A (pt) 1995-01-20 1996-01-10 Uso de compostos e processo para tratamento vasodilatador e profilaxia de por exemplo isquemia cerebral angina pectoris ou sindrome de raynaud

Country Status (13)

Country Link
US (1) US5886021A (pt)
EP (1) EP0804188A1 (pt)
JP (1) JPH10513154A (pt)
KR (1) KR19980701548A (pt)
CN (1) CN1168100A (pt)
AU (1) AU4329196A (pt)
BR (1) BR9606767A (pt)
CA (1) CA2208852A1 (pt)
CZ (1) CZ211897A3 (pt)
HU (1) HUP9800297A3 (pt)
IL (1) IL116827A (pt)
NO (1) NO973341L (pt)
WO (1) WO1996022093A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2581316C (en) 2004-09-21 2013-09-10 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
ES2773753T3 (es) 2010-11-01 2020-07-14 Mei Pharma Inc Compuestos isoflavonoides y métodos para el tratamiento del cáncer
PL2953938T3 (pl) 2014-02-07 2017-12-29 Novogen Ltd. Funkcjonalizowane związki benzopiranowe i ich zastosowanie
AU2016215515B2 (en) 2015-02-02 2020-04-30 Mei Pharma, Inc. Combination therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
US3822287A (en) * 1969-04-17 1974-07-02 Rexall Drug Chemical Process for preparation of substituted 3,4-(diphenyl)chromans
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives

Also Published As

Publication number Publication date
KR19980701548A (ko) 1998-05-15
US5886021A (en) 1999-03-23
AU4329196A (en) 1996-08-07
HUP9800297A2 (hu) 1998-12-28
CZ211897A3 (en) 1997-12-17
CA2208852A1 (en) 1996-07-25
IL116827A (en) 1999-11-30
CN1168100A (zh) 1997-12-17
EP0804188A1 (en) 1997-11-05
MX9705379A (es) 1997-10-31
JPH10513154A (ja) 1998-12-15
HUP9800297A3 (en) 1999-12-28
NO973341D0 (no) 1997-07-18
WO1996022093A1 (en) 1996-07-25
NO973341L (no) 1997-07-18
IL116827A0 (en) 1996-05-14

Similar Documents

Publication Publication Date Title
PT712860E (pt) Processo para purificacao e isolamento de 2'-deoxi-2', 2'-difluoronucleosidos
PT1002146E (pt) Processo para o processamento de misturas polimericas para obter filamentos
ITMI941252A0 (it) Composizione catalitica e processo per l'alchilazione di composti aromatici
ITMI962603A0 (it) Composizione catalitica e processo per l'alchilazione e/o la transalchilazione di composti aromatici
BR9708093A (pt) Composto formulação uso composto e processo para tratamento de distúrbios mediados por 5-hidroxitriptamina e para preparação do composto
BR9400475A (pt) Processo de preparação de zeólita modificada e zeólita modificada
BR9402038A (pt) Processo de purificação de pentaflúor etano
BR9707741A (pt) Processo para producão de particulas de detergente particulas de detergente e composicão detergente
BR9400368A (pt) Processo para isolamento e purificação de trehalose
BR9602638A (pt) Processo para purificação de melamina
BR9005793A (pt) Composicao de fluoreto estanoso aquoso estabilizada e processo para preparacao da mesma
BR9706967A (pt) Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausa
BR9800557A (pt) Processo contínuo para preparação de 4-aminopiperidinas
BR9403241A (pt) Composição de condicionamento de cabelo, e, processo para condicionar cabelo
BR9606767A (pt) Uso de compostos e processo para tratamento vasodilatador e profilaxia de por exemplo isquemia cerebral angina pectoris ou sindrome de raynaud
BR9400338A (pt) Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano
BR9606766A (pt) Utilização de compostos e processo para o tratamento e profilaxia de disturbios degenerativos cerebrais
BR9707173A (pt) Processo para a preparação de um composto e composto
BR9707475A (pt) Processo para a preparação de componente ativador de alvejamento em partículas
BR9404156A (pt) Processo para purificação de indigo
BR9706239A (pt) Processo para preparação de 3-(1-hidroxifenil-1-alcoxiimino-metil)dioxazinas
BR9302417A (pt) Processo para purificacao de indigo
BR9305707A (pt) Processo para preparaçao de 3-acilestratrienos e acilbenzenos
BR9611282A (pt) Composição detergente sólida processo para fabricá-la e uso da mesma
PT998470E (pt) Processo de preparacao de derivados aminados de alquiloxifuranona compostos provenientes desse processo e utilizacao desses compostos

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)